We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Herbal Remedies Interfere with Lab Tests

By HospiMedica staff writers
Posted on 06 Aug 2004
A study has found that herbal medicines interfere with clinical laboratory testing and also pose a risk to people taking prescription medicines. More...
These and other findings were reported at the annual meeting of the American Association for Clinical Chemistry (AACC) in Los Angeles (CA, USA) in July 2004.

Despite the lack of any efficacy evidence and the fact that no scientific investigation has identified effective dosage levels, 60% of people in the United States believe herbal medicines are safe and effective, according to the study. Yet herbal medicines contain crude mixtures of active and toxic components that can have adverse effects on users.

The U.S. Food and Drug Administration (FDA) continues to allow herbal remedies to be marketed as dietary supplements in spite of the risks they pose. For example, St. John's Wort can dangerously double the effect of any prescription medication and also put people at undue risk of excessive sun exposure. Certain Chinese herbs such as comfrey and kava kava can cause abnormal liver function, liver damage, lead poisoning, and can aggravate hypertension. Gingko, garlic, and ginseng thin the blood and may cause internal bleeding.

Another study finding was that 80% of the people in Africa rely on herbal medicines because they cannot afford Western prescription drugs. The study was conducted by Amitava Dasgupta, professor of pathology and laboratory medicine, University of Texas-Houston Medical School (USA).




Related Links:
U. of Texas-Houston

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.